| Pharmaceutical active ingredients: |
| Nystatin |
| Available forms, composition and doses of Mycostatine Forte: |
| Gel; Topical; Nystatin 200,000 units / g |
| Mycostatine Forte medical category: |
| Human:AntifungalsPolyenesPreparations for vaginal conditions |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A07AA02 - NystatinD01AA01 - NystatinG01AA01 - Nystatin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bristol-Myers SquibbSanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Mycolog-II | Nystatin; Triamcinolone Acetonide | Bristol-Myers Squibb; Apothecon |
| Mycostatin | Nystatin | Bristol-Myers Squibb; Apothecon; ConvaTec; Dermapharm; DKSH; Institute of Pharmaceutical Research and Technology; Sanofi-Aventis; Sarabhai Piramal Pharma; Westwood-Squibb |
| Mycostatin Forte | Nystatin | Bristol-Myers Squibb; Sanofi-Aventis |
| Mycostatin V | Gramicidin; Neomycin Sulfate; Nystatin; Triamcinolone Acetonide | Bristol-Myers Squibb; Dermapharm |
| Mycostatine | Nystatin | Bristol-Myers Squibb; Sanofi-Aventis |
| Mycostatin-Zinkoxid | Nystatin; Zinc Oxide | Bristol-Myers Squibb; Dermapharm |
| Mykoproct | Lidocaine Hydrochloride; Nystatin; Triamcinolone Acetonide | Bristol-Myers Squibb |
| Mysteclin | Amphotericin B; Tetracycline | Bristol-Myers Squibb; Dermapharm |
| Mystecline | Nystatin; Tetracycline Hydrochloride | Bristol-Myers Squibb |
| Mysteclin-F | Amphotericin B; Tetracycline | Bristol-Myers Squibb |